Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
The Lancet. Oncology
|
September 6, 2017
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
Uwe Platzbecker, Ulrich Germing, Katharina S Götze, et al.
Clinical Chemistry and Laboratory Medicine
|
May 11, 2023
One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation
Friederike Häuser, Jens Mittler, Misra Simge Hantal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2013
Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells
Anastasija Michel, Andrea Schüler, Pamela Friedrich, et al.
EXCLI Journal
|
February 28, 2022
Hypermethylation of <i>RAD9A</i> intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation
Danuta Galetzka, Julia Böck, Lukas Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Uwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Hemasphere
|
April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria
Mareike Tometten, Martin Kirschner, Robert Meyer, et al.
The Lancet. Oncology
|
June 9, 2019
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
Jorge E Cortes, Samer Khaled, Giovanni Martinelli, et al.
Blood Advances
|
February 12, 2025
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort
Mareike Tometten, Fabian Beier, Martin Kirschner, et al.
Science (New York, N.Y.)
|
March 12, 2021
Lipid presentation by the protein C receptor links coagulation with autoimmunity
Nadine Müller-Calleja, Anne Hollerbach, Jennifer Royce, et al.
The Journal of Clinical Investigation
|
July 2, 2026
Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models
Marco Jessen, KyungMok Kim, Marie Tollot-Wegner, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
The Lancet. Oncology
|
September 6, 2017
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
Uwe Platzbecker, Ulrich Germing, Katharina S Götze, et al.
Clinical Chemistry and Laboratory Medicine
|
May 11, 2023
One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation
Friederike Häuser, Jens Mittler, Misra Simge Hantal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2013
Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells
Anastasija Michel, Andrea Schüler, Pamela Friedrich, et al.
EXCLI Journal
|
February 28, 2022
Hypermethylation of <i>RAD9A</i> intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation
Danuta Galetzka, Julia Böck, Lukas Wagner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Uwe Platzbecker, Katharina S Götze, Philipp Kiewe, et al.
Hemasphere
|
April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria
Mareike Tometten, Martin Kirschner, Robert Meyer, et al.
The Lancet. Oncology
|
June 9, 2019
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
Jorge E Cortes, Samer Khaled, Giovanni Martinelli, et al.
Blood Advances
|
February 12, 2025
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort
Mareike Tometten, Fabian Beier, Martin Kirschner, et al.
Science (New York, N.Y.)
|
March 12, 2021
Lipid presentation by the protein C receptor links coagulation with autoimmunity
Nadine Müller-Calleja, Anne Hollerbach, Jennifer Royce, et al.
The Journal of Clinical Investigation
|
July 2, 2026
Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models
Marco Jessen, KyungMok Kim, Marie Tollot-Wegner, et al.
Page
of 4